In contrast, lower DRAIC expression was observed in cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), glioblastoma multiforme (GMB), kidney chromophobe (KICH), kidney renal papillary cell carcinoma (KIRP), LUSC, and rectum adenocarcinoma (READ), compared to normal tissues (Figure 2). This evidence concerns the gene DRAIC and cholangiocarcinoma.